Please assess the completion status of the following clinical trial:

Trial Title: Introduction of an Oral Live Human Rotavirus (Rotarix) Vaccine in Matlab

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* A male or female infant at least 6 weeks of age and not older than 20 weeks of age at the time of first dose of Rotarix.~* An infant whose parent or guardian's primary residence, at the time of first EPI vaccinations, is a village selected to receive Rotarix.~* Written informed consent obtained from the parent or guardian of the subject, prior to the subject's first study vaccination~Exclusion Criteria:~* Hypersensitivity to the active substance or any component in the vaccine~* Hypersensitivity after previous administration of rotavirus vaccines.~* Previous history of intussusception.~* Subjects with uncorrected congenital malformation of the gastrointestinal tract that would predispose for intussusception.~* Infants with known or suspected immunodeficiency.~* Administration of Rotarix should be postponed in subjects suffering from an acute severe febrile illness only if that illness also results in postponement of other EPI vaccinations.

- Gender: ALL
- Minimum Age: 6 Weeks
- Maximum Age: 20 Weeks
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): All eligible children in the experimental arm will be vaccinated with the Rotavirus vaccine
- 2 (Type: NO_INTERVENTION): Children will not be vaccinated with rotavirus vaccine.

Based on this trial design, predict the completion outcome and termination type (if applicable).